Cardinal Health traded at $223.18 this Wednesday March 4th, decreasing $3.17 or 1.40 percent since the previous trading session. Looking back, over the last four weeks, Cardinal Health lost 1.76 percent. Over the last 12 months, its price rose by 75.15 percent. Looking ahead, we forecast Cardinal Health to be priced at 222.22 by the end of this quarter and at 202.43 in one year, according to Trading Economics global macro models projections and analysts expectations.
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources and distributes a range of medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. This segment also distributes a range of national brand products and provides supply chain services and solutions to hospitals and other healthcare providers.